EDITORIAL
Published on 10 Dec 2018
Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction
doi 10.3389/fphys.2018.01777
- 1,754 views
- 1 citation
- Frontiers in Physiology
- Respiratory Physiology and Pathophysiology
- Research Topics
- Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction
Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction
20k
Total downloads
75k
Total views and downloads
Articles
REVIEW
Published on 20 Aug 2018
Inflammation in Right Ventricular Failure: Does It Matter?
doi 10.3389/fphys.2018.01056
- 4,709 views
- 47 citations
ORIGINAL RESEARCH
Published on 25 Jul 2018
Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention
doi 10.3389/fphys.2018.00955
- 4,042 views
- 15 citations
REVIEW
Published on 13 Jul 2018
Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
doi 10.3389/fphys.2018.00890
- 6,398 views
- 28 citations
ORIGINAL RESEARCH
Published on 10 Jul 2018
Increased Drp1-Mediated Mitochondrial Fission Promotes Proliferation and Collagen Production by Right Ventricular Fibroblasts in Experimental Pulmonary Arterial Hypertension
doi 10.3389/fphys.2018.00828
- 7,220 views
- 67 citations
REVIEW
Published on 19 Jun 2018
Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach
doi 10.3389/fphys.2018.00587
- 5,886 views
- 33 citations
ORIGINAL RESEARCH
Published on 01 Jun 2018
Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension
doi 10.3389/fphys.2018.00555
- 5,621 views
- 24 citations
REVIEW
Published on 31 May 2018
Pulmonary Arterial Hypertension: Iron Matters
doi 10.3389/fphys.2018.00641
- 9,597 views
- 24 citations
REVIEW
Published on 23 May 2018
Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers
doi 10.3389/fphys.2018.00609
- 5,221 views
- 54 citations
ORIGINAL RESEARCH
Published on 15 May 2018
Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
doi 10.3389/fphys.2018.00537
- 4,648 views
- 26 citations
ORIGINAL RESEARCH
Published on 09 Apr 2018
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
doi 10.3389/fphys.2018.00271
- 4,500 views
- 27 citations
ORIGINAL RESEARCH
Published on 27 Mar 2018
The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
doi 10.3389/fphys.2018.00180
- 7,788 views
- 55 citations
